Pete Hudson

Pete Hudson has made 63 investments in companies such as: Lassen Therapeutics, Avid Radiopharmaceuticals, Nereus Pharmaceuticals, Calistoga Pharmaceuticals, Chimerix, Sutro Biopharma, Larimar Therapeutics, Aegis Semiconductor, Esperion Therapeutics, Taligen Therapeutics, Coapt Systems, Tyra Biosciences, GenePeeks, DispatchHealth, ChemoCentryx, Sunesis Pharmaceuticals, Intradigm Corporation, SurgRx, PneumRx, PatientsLikeMe, Cara Therapeutics, Immune Design, Sonexa Therapeutics, Trevena, Excaliard Pharmaceuticals, Xelerated, MacroGenics, St. George's University, SARcode Bioscience, Neothetics, Kite Pharma, Sierra Surgical, VertiFlex, Virobay, CymaBay Therapeutics, Allakos, EGenesis, ZS Pharma, Everside Health, Portola Pharmaceuticals, TransMedics, Aegerion Pharmaceuticals, Vir Biotechnology, Pathwork Diagnostics, MAKO Surgical, CuraSen Therapeutics, Aerovance, Achaogen, Evofem Biosciences, Aerie Pharmaceuticals, Be Biopharma, Anesiva, Kiadis Pharma, Carbylan Therapeutics, Applied Genetics Technologies Corporation, Variant Bio, Lumena Pharmaceuticals, Corcept Therapeutics, aTyr Pharma, Foldrx Pharmaceuticals, 7TM Pharma, Novome Biotechnologies, Qihan Biotech.

Location of Pete Hudson is Denver, United States.

The free version of Angel Match provides limited data for Pete Hudson. Advanced features and premium data such as emails, phone numbers and social media profiles are available only on paid subscription plans.

Pete Hudson is a Managing Director and he his investment types are: Venture Capital.
Pete Hudson focuses investing in industries such as: Health Care, Home Health Care, Medical, mHealth, Biopharma, Biotechnology, Genetics, Life Science, Women Founded, Information Services, Software, Therapeutics.

A short brief about investor:


Past investments

Social media:

Available after registration.